DNV GL Receives Deeming Authority to Accredit Psychiatric Hospitals Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 05:21

Milford, Ohio, July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 04:00

VALENCIA, Calif., July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
Verata Health and Olive Join Forces to Solve $31B Prior Authorization Issue Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 04:00

MINNEAPOLIS, July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
Philips launches pre-hospital wireless monitoring solution for emergency medical response in U.S. Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 04:00

July 29, 2020

  • Philips receives 510(k) clearance from the FDA for its professional defibrillator (Tempus LS- Manual), now offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S.
  • Solution delivers real-time bidirectional data transfer for remote patient monitoring, giving EMS responders a new approach to pre-hospital care

Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the U.S. The solution is a complete end-to-end system that combines innovative hardware and advanced software to expand the pre-hospital scope of care for first responders. The professional defibrillator (Tempus LS-Manual) is the final element of the overall solution to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale in the U.S. market.

As a unique modular platform, the remote monitoring and defibrillator solution (Tempus ALS) consists of a remote portable vital signs patient monitor (Tempus Pro), and remote professional defibrillator (Tempus LS-Manual). While the monitor and defibrillator can be used separately, the devices also connect wirelessly to share data and transfer vitals, waveforms and images into Philips web-based software platform (IntelliSpace Corsium). The software platform provides robust, real-time transfer of clinical data and events, interactive ECG measurement, two-way communication and more, enabling rapid clinical and transport decision support and seamless electronic patient care recording (ePCR) integration outside the hospital in emergency settings.

“In emergency situations, where seconds count, having access to advanced patient data collection and sharing and real-time secure data streaming, can help inform confident treatment and transport decisions outside the hospital,” said Arman Voskerchyan, General Manager of Therapeutic Care at Philips. “The integrated remote monitoring and defibrillator solution combined with our web-based software platform will help front line responders provide emergency care, diagnosis and treatment - including defibrillation therapy, data management and clinical and operational efficiency features – in a fully integrated solution.”

Emergencies and care events outside the hospital continue to rise, with an estimated 240 million calls made to 9-1-1 in the U.S. each year [1]. In addition to the stress of the unknown and what to expect at the scene of the call, emergency medical providers must deal with manual handling issues. Equipment carried is heavy, often damaged due to use in unpredictable conditions and has limited data connectivity – inhibiting the ability for on-scene support. In an effort to address these challenges, both elements of the Philips remote monitoring and defibrillator (Tempus ALS) solution are designed with a small, rugged exterior and long-lasting battery to allow emergency medical providers to focus on caring for the patient without the hassle or distraction of bulky equipment.

Philips leadership in Emergency Care solutions
Earlier this year, Philips launched its new emergency care informatics suite in the U.S. market, previously in use in Europe, helping care teams spot life-threatening conditions remotely, improve accuracy of support from on-scene crews, and enhance tailoring of in-hospital care based on pre-hospital physiology. In October 2019, Philips announced a first-of-its-kind collaboration with Air Ambulance Kent Surrey Sussex (AAKSS) where helicopter Emergency Service (HEMS) teams were able to live stream patient medical information from the scene to the hospital through the Philips pre-hospital solution. Philips offers a wide range of emergency care offerings, including automated external defibrillators (AEDs), advanced life support monitors, and more. Visit Philips Emergency Care and Resuscitation for more information on the remote monitoring and defibrillator solution and Philips broad portfolio of Emergency Care solutions.
[1] https://www.nena.org/page/911Statistics

For further information, please contact:

Kathy O'Reilly 
Philips Global Press Office
Tel: +1 978-221-8919
E-mail :  This e-mail address is being protected from spambots. You need JavaScript enabled to view it

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at Read more...

 
Conversion Labs to Host Second Quarter Conference Call on Monday, August 17, 2020 at 1:00 p.m. ET Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:31

NEW YORK, July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
InveniAI Enters Strategic Artificial Intelligence (AI) and Machine Learning (ML) Focused Collaboration with GlaxoSmithKline Consumer Healthcare Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:30
  • Three-year strategic collaboration to leverage InveniAI’s AI- and ML-powered Platform, AlphaMeld® after a successful proof-of-value collaboration
  • AlphaMeld® will capture consumer-specific innovation for both internal and external R&D

GUILFORD, Conn., July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
Auris Medical Announces Completion of Enrollment into First Part of TRAVERS Phase 2 Study with AM-125 in Vertigo Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:30
Read more...
 
Smile Direct Club Now Serving Orthodontia’s Largest and Fastest-Growing Segment: Teens Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:29

SmileDirectClub Teen program expands medtech pioneer’s mission to increase access to premium oral care

New offering includes groundbreaking, patented aligner case powered by Tile™

NASHVILLE, Tenn., July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
AnPac Bio Completes Over 180,000 CDA-Based Cancer Risk Assessment Tests Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:26

SAN JOSE, Calif., July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New Capital Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:05
  • Aggregate of $71 million of ATM proceeds executed at weighted average price of $7.70 per share
  • Received $20 million first tranche from $50 million debt facility with K2 HealthVentures
  • Cash on hand of $101 million expected to fund operations into third quarter of 2021
  • Provides strategic flexibility post Phase 3 systemic sclerosis topline data readout later this summer

Norwood, MA, July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
Arbutus to Report Second Quarter 2020 Financial Results Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 03:00

WARMINSTER, Pa., July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
Myriad Launches Proprietary AMPLIFY™ Technology, Further Increasing the Performance of its Prequel™ NIPS Test Print E-mail
GlobeNewswire
Wednesday, 29 July 2020 02:05

SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE)

Read more...
 
HCMC Announces Expiration of its Series A Warrants Print E-mail
GlobeNewswire
Tuesday, 28 July 2020 11:05

HOLLYWOOD, FL, July 28, 2020 (GLOBE NEWSWIRE)

Read more...
 
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020 Print E-mail
GlobeNewswire
Tuesday, 28 July 2020 11:01

AUSTIN, Texas, July 28, 2020 (GLOBE NEWSWIRE)

Read more...
 
Employment and labor lawyer rejoins Norton Rose Fulbright in Los Angeles Print E-mail
GlobeNewswire
Tuesday, 28 July 2020 07:51

Los Angeles, July 28, 2020 (GLOBE NEWSWIRE)

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 7 of 281

Newsletter